Literature DB >> 10580639

The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy.

V K Singh1, S Mehrotra, S S Agarwal.   

Abstract

In the past few years, considerable evidence has accumulated to suggest the existence of functionally polarized responses by the CD4+ T helper (Th)--and the CD8+ T cytotoxic (Tc)-cell subsets that depend on the cytokines they produce. The Th1 and Th2 cellular immune response provide a useful model for explaining not only the different types of protection, but also the pathogenic mechanisms of several immunopathological disorders. The factors responsible for the polarization of specific immune response into a predominant Th1 or Th2 profile have been extensively investigated in mice and humans. Evidence has accumulated from animal models to suggest that Th1-type lymphokines are involved in the genesis of organ-specific autoimmune diseases, such as experimental autoimmune uveitis, experimental allergic encephalomyelitis, or insulin-dependent diabetes mellitus. Accordingly, data so far available in human diseases favor a prevalent Th1 lymphokine profile in target organs of patients with organ-specific autoimmunity. By contrast, Th2-cell predominance was found in the skin of patients with chronic graft-versus host disease, progressive systemic sclerosis, systemic lupus erythematosus, and allergic diseases. The Th1/Th2 concept suggests that modulation of relative contribution of Th1- or Th2-type cytokines regulate the balance between protection and immunopathology, as well as the development and/or the severity of some immunologic disorders. In this review, we have discussed the paradigm of Th1 and Th2 cytokines in relation to autoimmunity and allergy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580639     DOI: 10.1007/BF02786470

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  94 in total

1.  Human TH1 and TH2 subsets: doubt no more.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1991-08

Review 2.  Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.

Authors:  S L Constant; K Bottomly
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 3.  Th1 and Th2 cells in autoimmunity.

Authors:  P Druet; R Sheela; L Pelletier
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

Review 4.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 5.  Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

Authors:  R S Liblau; S M Singer; H O McDevitt
Journal:  Immunol Today       Date:  1995-01

6.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

Review 7.  Lymphokine production by human T cells in disease states.

Authors:  S Romagnani
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  TH2-type infiltrating T cells in nickel-induced contact dermatitis.

Authors:  P Probst; D Küntzlin; B Fleischer
Journal:  Cell Immunol       Date:  1995-10-01       Impact factor: 4.868

Review 9.  The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes.

Authors:  B Balasa; N Sarvetnick
Journal:  J Autoimmun       Date:  1996-04       Impact factor: 7.094

10.  Effect of adjuvant therapy on development of diabetes in mouse and man.

Authors:  N Shehadeh; F Calcinaro; B J Bradley; I Bruchim; I Bruchlim; P Vardi; K J Lafferty
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

View more
  66 in total

1.  Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; C Burkhart; A E Cribb; W J Pichler; B K Park
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses.

Authors:  María Mittelbrunn; Ana Molina; María M Escribese; María Yáñez-Mó; Ester Escudero; Angeles Ursa; Reyes Tejedor; Francisco Mampaso; Francisco Sánchez-Madrid
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

3.  Cellular immune activation in Gulf War veterans.

Authors:  Anna Skowera; Matthew Hotopf; Elzbieta Sawicka; Ruben Varela-Calvino; Catherine Unwin; Vasilis Nikolaou; Lisa Hull; Khalida Ismail; Anthony S David; Simon C Wessely; Mark Peakman
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.317

4.  Multiple sclerosis review.

Authors:  Marvin M Goldenberg
Journal:  P T       Date:  2012-03

5.  Tumor necrosis factor inhibitor-associated dermatomyositis.

Authors:  Rachel Klein; Misha Rosenbach; Ellen J Kim; Brian Kim; Victoria P Werth; Jonathan Dunham
Journal:  Arch Dermatol       Date:  2010-07

6.  Immunological dysfunction, vaccination and Gulf War illness.

Authors:  Mark Peakman; Ania Skowera; Matthew Hotopf
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

7.  Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder.

Authors:  Mani N Pavuluri; David B Henry; Melissa Moss; Tahseen Mohammed; Julie A Carbray; John A Sweeney
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

8.  Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Harald Weninger; Christina Patrick; Anthony Adame; Radmila Santic; Stefanie Meindl; Benjamin Vigl; Oskar Smrzka; Achim Schneeberger; Frank Mattner; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-14       Impact factor: 17.088

9.  Distinct roles of helper T-cell subsets in a systemic autoimmune disease.

Authors:  Katrina K Hoyer; Wilson F Kuswanto; Eugenio Gallo; Abul K Abbas
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

10.  Tumour-Associated Tissue Eosinophilia in Oral Squamous Cell Carcinoma- A Boon or a Bane?

Authors:  Shweta Yellapurkar; Srikant Natarajan; Karen Boaz; Mohan Baliga; Premalatha Shetty; Nidhi Manaktala; Mukul Prasad; Mahalakshmi Ravi
Journal:  J Clin Diagn Res       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.